Tesofensine

Buy Tesofensine Online

Tesofensine is a centrally acting inhibitor of norepinephrine, dopamine, and serotonin reuptake that has been investigated primarily for weight management. Clinical trials have demonstrated substantial weight-loss effects, while also identifying cardiovascular and stimulant-like considerations.

Product Information

Tesofensine works by inhibiting presynaptic reuptake of three monoamines: noradrenaline, dopamine, and serotonin. In a phase 2 obesity trial, 0.25, 0.5, and 1.0 mg once-daily doses were studied over 24 weeks.

How It Works

Tesofensine increases signaling from norepinephrine, dopamine, and serotonin by reducing their reuptake. The combined activity can suppress appetite and alter central nervous system pathways involved in energy balance.

POTENTIAL BENEFITS

1. Significant Weight-Loss Potential

Clinical research demonstrated meaningful reductions in body weight with Tesofensine, with greater average weight loss at higher doses in the phase 2 trial.

2. Appetite Regulation

Tesofensine's action on several monoamine neurotransmitters can influence central appetite-control pathways, providing a pharmacological basis for its weight-management effects.

3. Metabolic Research Potential

The magnitude of weight reduction observed in clinical studies has made Tesofensine an important research compound in the search for more effective pharmacological approaches to obesity.

4. Once-Daily Administration

Clinical trials evaluated Tesofensine as a once-daily oral treatment, providing a straightforward dosing model during its clinical development.

Dosage

In a phase 2 obesity trial, Tesofensine was studied at 0.25 mg, 0.5 mg, and 1.0 mg once daily for 24 weeks. The 0.5 mg group produced substantial weight loss but also showed an average increase in heart rate, demonstrating why dose selection requires medical oversight.

Side Effects

Reported adverse effects included dry mouth, nausea, constipation, diarrhea, hard stools, and insomnia. Increased heart rate was also observed, particularly at 0.5 mg, making cardiovascular monitoring an important consideration.

References

1. PubMed - Tesofensine obesity clinical trial PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.